Company Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Quanterix Corporation

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
15.56 ^USD	-0.19%		-1.71%	-43.09%

Apr. 12	Quanterix Corporation Announces Laurie Olson, Director Will Not Stand for Re-Election	CI
Mar. 25	Transcript : Quanterix Corporation - Special Call

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

Number of employees: 441

USD in Million	2016	Weight	2017	Weight	Delta
Consumable and Other Product 33.4 %	4	25.2 %	8	33.4 %	+72.08%
Instrument 28.4 %	6	35.1 %	6	28.4 %	+5.30%
Simoa Accelerator Lab Services 21.2 %	3	17.6 %	5	21.2 %	+57.15%
Other Services 12.3 %	2	10.9 %	3	12.3 %	+46.72%
Collaboration and License 4.7 %	2	11.2 %	1	4.7 %	-45.54%

USD in Million	2022	Weight	2023	Weight	Delta
North America 62.5 %	65	61.8 %	77	62.5 %	+17.33%
EMEA 25.8 %	28	26.3 %	32	25.8 %	+13.85%
Asia Pacific 11.7 %	13	11.9 %	14	11.7 %	+13.53%

Managers	Title	Age	Since
Masoud Toloue CEO	Chief Executive Officer	43	21-06-08
Vandana Sriram DFI	Director of Finance/CFO	51	23-08-20
Martin Madaus CHM	Chairman	64	10-10-31
Alexandra Phillips CTO	Chief Tech/Sci/R&D Officer	-	21-12-31
Daniel Pikora COO	Chief Operating Officer	49	22-04-30
David C. Duffy CTO	Chief Tech/Sci/R&D Officer	53	07-06-30
Mark Roskey CTO	Chief Tech/Sci/R&D Officer	64	14-09-18
Ed Joyce IRC	Investor Relations Contact	-	-
Erica Bell HRO	Human Resources Officer	51	21-12-31
Laurie A. Churchill LAW	General Counsel	53	23-01-31

Members of the board	Title	Age	Since
Martin Madaus CHM	Chairman	64	10-10-31
Sarah Hlavinka McConnell BRD	Director/Board Member	59	19-07-24
Brian J. Blaser BRD	Director/Board Member	59	23-01-05
Laurie Olson BRD	Director/Board Member	61	21-04-26
David Walt FOU	Founder	71	07-03-31
William Donnelly BRD	Director/Board Member	62	23-08-20
Paul Meister BRD	Director/Board Member	71	13-08-14
Karen Flynn BRD	Director/Board Member	61	22-06-05
Masoud Toloue CEO	Chief Executive Officer	43	21-06-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	38,247,078	35,770,893 ( 93.53 %)	0	93.53 %

Name	Equities	%	Valuation
BlackRock Advisors LLC 7.838 %	2,983,511	7.838 %	70 M $
Millennium Management LLC 5.805 %	2,209,566	5.805 %	52 M $
Vanguard Fiduciary Trust Co. 5.399 %	2,055,033	5.399 %	48 M $
David Walt 3.768 %	1,434,259	3.768 %	34 M $
Lord, Abbett & Co. LLC 3.758 %	1,430,277	3.758 %	34 M $
Portolan Capital Management LLC 3.408 %	1,297,090	3.408 %	31 M $
Gilder, Gagnon, Howe & Co. LLC 3.159 %	1,202,408	3.159 %	28 M $
Dimensional Fund Advisors LP 2.559 %	974,111	2.559 %	23 M $
Invesco Advisers, Inc. 2.286 %	870,026	2.286 %	20 M $
Ashford Capital Management, Inc. 2.186 %	831,885	2.186 %	20 M $

Quanterix Corp.

Building 1 900 Middlesex Turnpike

01821, Billerica

http://www.quanterix.com

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.56 USD

Average target price

29.8 USD

Spread / Average Target

+91.52%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
QUANTERIX CORPORATION	-43.09%	595M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology